I’m looking forward to seeing validation of these agreements, ie...

I’m looking forward to seeing validation of these agreements, ie Revenue through sales.
I see that as the material de risk to DTZ. That and FDA approval.
I used to go all in on early growth stocks once they announced their first distribution agreements and learnt the hard way that it didn’t matter how much I believed, the outcome wasn’t predictable, probably lost more than I gained on that approach.
It’s because of these experiences that I’m hesitant to buy more right now, despite the urge and the compelling product offering.
Ideally, for those that want more, like me, revenue growth prior to FDA would be nice, 1st de risk event, then top up. The purchase orders further validate the product. Then FDA…..
Either way, I’m in already so fingers crossed.